0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Research Letter |  FREE
Johann Steiner, MD, PhD; Bianca Teegen, PhD; Kolja Schiltz, MD, PhD; et al.
JAMA Psychiatry. 2014;71(7):838-839. doi:10.1001/jamapsychiatry.2014.469.
Includes: Supplemental Content

Original Article |  FREE
Myrna M. Weissman, PhD; Raz Gross, MD, MPH; Abby Fyer, MD; et al.
Arch Gen Psychiatry. 2004;61(3):273-279. doi:10.1001/archpsyc.61.3.273.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
Related JAMA Psychiatry Collections
From The JAMA Network
JAMA Ophthalmology
JAMA Ophthalmology Clinical Challenge  | 
Reduced Visual Acuity Following Kidney Stone Extraction
Malini Veerappan, BA; Michael Seider, MD; Sharon Fekrat, MD
JAMA Oncology
Original Investigation  | 
Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered A Post hoc Analysis of the Mainsail Study
Ellen S. de Morrée, MSc; Nicholas J. Vogelzang, MD; Daniel P. Petrylak, MD; et al.
JAMA Oncology
Viewpoint  | 
Intermittent Androgen Deprivation Primum Non Nocere—“First Do NO Harm”
Maha Hussain, MD; Mario Eisenberger, MD
JAMA Oncology
Viewpoint  | 
Intermittent Androgen Deprivation Therapy—An Important Treatment Option for Prostate Cancer
Laurence Klotz, MD, FRCSC, CM; Celestia S, Higano, MD